Emerald Advisers LLC Makes New $10.61 Million Investment in Mirion Technologies, Inc. (NYSE:MIR)

Emerald Advisers LLC bought a new stake in Mirion Technologies, Inc. (NYSE:MIR) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 607,991 shares of the company’s stock, valued at approximately $10,609,000. Emerald Advisers LLC owned about 0.26% of Mirion Technologies as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in the company. Swiss National Bank lifted its stake in Mirion Technologies by 0.5% in the fourth quarter. Swiss National Bank now owns 376,800 shares of the company’s stock valued at $6,575,000 after buying an additional 2,000 shares during the last quarter. Xponance Inc. raised its position in Mirion Technologies by 15.9% in the 4th quarter. Xponance Inc. now owns 14,942 shares of the company’s stock valued at $261,000 after purchasing an additional 2,048 shares during the last quarter. KBC Group NV boosted its stake in Mirion Technologies by 39.2% during the 4th quarter. KBC Group NV now owns 8,002 shares of the company’s stock worth $140,000 after purchasing an additional 2,254 shares during the period. Handelsbanken Fonder AB grew its position in Mirion Technologies by 10.5% during the 4th quarter. Handelsbanken Fonder AB now owns 61,031 shares of the company’s stock worth $1,065,000 after purchasing an additional 5,800 shares during the last quarter. Finally, Quest Partners LLC increased its stake in Mirion Technologies by 680.5% in the third quarter. Quest Partners LLC now owns 6,728 shares of the company’s stock valued at $74,000 after purchasing an additional 5,866 shares during the period. 78.51% of the stock is owned by institutional investors and hedge funds.

Mirion Technologies Price Performance

Mirion Technologies stock opened at $15.22 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.55 and a current ratio of 2.16. Mirion Technologies, Inc. has a one year low of $9.11 and a one year high of $18.81. The company has a market cap of $3.54 billion, a P/E ratio of -80.10 and a beta of 0.74. The business has a fifty day moving average of $15.69 and a two-hundred day moving average of $14.97.

Mirion Technologies (NYSE:MIR) last announced its earnings results on Tuesday, February 11th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.02. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. As a group, analysts predict that Mirion Technologies, Inc. will post 0.39 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MIR has been the subject of several recent research reports. Citigroup increased their target price on shares of Mirion Technologies from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, December 4th. Robert W. Baird started coverage on Mirion Technologies in a research report on Thursday, December 19th. They set an “outperform” rating and a $22.00 price objective for the company. The Goldman Sachs Group upped their price target on Mirion Technologies from $16.00 to $21.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, Baird R W raised shares of Mirion Technologies to a “strong-buy” rating in a research note on Thursday, December 19th. Three research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $19.25.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.